Member's blog

The treatments didn't significantly enhance walking or energy distance in individuals tested for those difficulties, based on the results in the New England Journal of Medicine. They discovered the event rate at three years was low in both the treated group at 5.5 percent and in the untreated group at 6.7 percent, suggesting a possible cardiovascular advantage of testostmore